留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x 关闭 永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

1例米卡芬净治疗有氟康唑暴露史念珠菌血症的病例分析及相关文献复习

秦又发,  张庆,  刘莉

downloadPDF
文章导航 > 药学实践与服务  > 2016 >  34(2): 181-183
秦又发, 张庆, 刘莉. 1例米卡芬净治疗有氟康唑暴露史念珠菌血症的病例分析及相关文献复习[J]. 药学实践与服务, 2016, 34(2): 181-183. doi: 10.3969/j.issn.1006-0111.2016.02.022
引用本文: 秦又发, 张庆, 刘莉. 1例米卡芬净治疗有氟康唑暴露史念珠菌血症的病例分析及相关文献复习[J]. 药学实践与服务, 2016, 34(2): 181-183. doi: 10.3969/j.issn.1006-0111.2016.02.022
shu
QIN Youfa, ZHANG Qing, LIU Li. Clinical analysis of 1 case of micafungin treatment: fluconazole-exposed candidemia and review of related literature[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(2): 181-183. doi: 10.3969/j.issn.1006-0111.2016.02.022
Citation: QIN Youfa, ZHANG Qing, LIU Li. Clinical analysis of 1 case of micafungin treatment: fluconazole-exposed candidemia and review of related literature[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(2): 181-183. doi: 10.3969/j.issn.1006-0111.2016.02.022
shu

1例米卡芬净治疗有氟康唑暴露史念珠菌血症的病例分析及相关文献复习

doi: 10.3969/j.issn.1006-0111.2016.02.022
  • 1.

    东莞市第三人民医院药学部, 广东 东莞 523326

  • 2.

    南方医科大学附属南方医院药学部, 广州 510515

  • 3.

    湖北医药学院附属随州医院药学部, 湖北 随州 441300

Clinical analysis of 1 case of micafungin treatment: fluconazole-exposed candidemia and review of related literature

  • 1.

    Department of Pharmacy, Third people's Hospital of Dongguan, Dongguan 523326, China

  • 2.

    Department of Pharmacy, Nanfang Hospital Affiliated to Southern Medical University, Guangzhou 510515, China

  • 3.

    Department of Pharmacy, Suizhou Hospital of Hubei Medicine College, Suizhou 441300, China

  • 摘要: 目的 探讨临床药师参与有氟康唑暴露史念珠菌血症患者治疗的对策及效果,为临床有效控制此类感染提供参考。 方法 在伏立康唑治疗该病患者效果不佳的情况下,临床药师建议采用米卡芬净抗念珠菌治疗。 结果 患者的念珠菌感染得到有效控制。 结论 米卡芬净能有效治疗近期(<30 d)有氟康唑暴露史的念珠菌血行感染。临床药师参与临床治疗实践,协助制订个体化治疗方案,有利于提高临床药物治疗水平。
    Abstract: Objective To investigate countermeasures and effects of clinical pharmacists participating in the treatment for fluconazole-exposure candidemia, and to provide reference for infectious control in the clinic. Methods Clinical pharmacists used their professional knowledge and suggested utilizing micafungin to treat candidemia, when voriconazole was ineffective in a patient with candidemia and fluconazole exposure history. Results The patient's candida bloodstream infection was finally controlled. Clinical pharmacists were highly complimented from the doctors, nurses and patients. Conclusion Micafungin is effective in treatment of candidemia with a recent(<30 days) fluconazole exposure history. The participation of clinical pharmacists is helpful to develop individual medicinal therapy in clinical treatment and can improve therapeutic effects.
  • [1] Pfaller MA, Diekema DJ.Epidemiology of invasive candidiasis:a persistent public health problem[J].Clin Microbiol Rev, 2007, 20(1):133-163.
    [2] Anunnatsiri S, Chetchotisakd P, Mootsikapun P.Fungemia in non-HIV-infected patients:a five-year review.[J].Int J Infect Dis, 2009, 13(1):90-96.
    [3] Playford EG, Lipman J, Sorrell TC.Management of invasive candidiasis in the intensive care unit.[J].Drugs, 2010, 70(7):823-839.
    [4] Pappas PG, Kauffman CA, Andes D,et al.Clinical practice guidelines for the management of candidiasis:2009 update by the Infectious Diseases Society of America.[J].Clin Infect Dis, 2009, 48(5):503-535.
    [5] Ostrosky-Zeichner L, Pappas PG.Invasive candidiasis in the intensive care unit[J].Crit Care Med, 2006, 34(3):857-863.
    [6] Sanford JP. 热病:桑福德抗微生物治疗指南[M].北京:中国协和医科大学出版社,2011:73.
    [7] Prasad PA, Fisher BT, Coffin SE,et al.Pediatric risk factors for candidemia secondary to and species[J].J Pediatric Infect Dis Soc, 2013, 2(3):263-266.
    [8] Shah DN, Yau R, Lasco TM,et al.Impact of prior inappropriate fluconazole dosing on isolation of fluconazole-nonsusceptible Candida species in hospitalized patients with candidemia[J].Antimicrob Agents Chemother, 2012, 56(6):3239-3243.
    [9] Borst A, Raimer MT, Warnock DW,et al.Rapid acquisition of stable azole resistance by candida glabrata isolates obtained before the clinical introduction of fluconazole[J].Antimicrob Agents Chemother, 2005, 49(2):783-787.
    [10] Lortholary O, Desnos-Ollivier M, Sitbon K,et al.Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia:a prospective multicenter study involving 2,441 patients[J].Antimicrob Agents Chemother, 2011, 55(2):532-538.
    [11] Magill SS, Shields C, Sears CL,et al.Triazole cross-resistance among Candida spp.:case report, occurrence among bloodstream isolates, and implications for antifungal therapy[J].J Clin Microbiol, 2006, 44(2):529-535.
    [12] Chang TP, Ho MW, Yang YL,et al.Distribution and drug susceptibilities of Candida species causing candidemia from a medical center in central Taiwan[J].J Infect Chemother, 2013.
    [13] Pfaller MA, Diekema DJ, Ostrosky-Zeichner L,et al.Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin:analysis and proposal for interpretive MIC breakpoints[J].J Clin Microbiol, 2008, 46(8):2620-2629.
    [14] Messer SA, Diekema DJ, Boyken L,et al.Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.[J].J Clin Microbiol, 2006, 44(2):324-326.
    [15] 胡晶,商洪才,李晶,等.血必净注射液治疗脓毒症的系统评价[J].解放军医学杂志,2010(1):9-12.
  • [1] 迟文雅, 袁艳, 李伟林, 吴茼妤, 俞媛.  负载骨髓间充质干细胞/白藜芦醇脂质体的水凝胶支架用于创伤性脑损伤治疗 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202406034
    [2] 张艺昕, 关欣怡, 王博宁, 闻俊, 洪战英.  二氢吡啶类钙离子拮抗药物手性分析及其立体选择性药动学研究进展 . 药学实践与服务, 2024, 42(8): 319-324. doi: 10.12206/j.issn.2097-2024.202308062
    [3] 王鹏, 陈顺, 赵逸, 高守红, 王志鹏.  卡培他滨致小鼠手足综合征模型的建立及评价 . 药学实践与服务, 2024, 42(9): 385-388, 398. doi: 10.12206/j.issn.2097-2024.202308045
    [4] 李想, 陆鸿远, 张明玉, 高欢, 姚东, 许子华.  米格列醇激活UCP1介导棕色脂肪对冷暴露小鼠损伤的研究 . 药学实践与服务, 2024, 42(): 1-6. doi: 10.12206/j.issn.2097-2024.202404005
    [5] 史生辉, 石飞, 雷琼, 王亚峰, 吴雪花.  青藏高原肺结核合并念珠菌感染患者的病原菌分布特点及耐药率分析 . 药学实践与服务, 2024, 42(6): 260-262, 272. doi: 10.12206/j.issn.2097-2024.202304014
    [6] 郭灵怡, 刘艳超, 高路, 刘瑞瑶, 吕权真, 俞媛.  醋酸卡泊芬净单硬脂酸甘油酯纳米粒抗白色念珠菌感染的增效作用研究 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202310043
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  3419
  • HTML全文浏览量:  357
  • PDF下载量:  10
  • 被引次数: 0
出版历程
  • 收稿日期:  2014-08-02
  • 修回日期:  2015-08-28

1例米卡芬净治疗有氟康唑暴露史念珠菌血症的病例分析及相关文献复习

doi: 10.3969/j.issn.1006-0111.2016.02.022
  • 1. 东莞市第三人民医院药学部, 广东 东莞 523326
  • 2. 南方医科大学附属南方医院药学部, 广州 510515
  • 3. 湖北医药学院附属随州医院药学部, 湖北 随州 441300
  • 收稿日期: 2014-08-02
  • 修回日期: 2015-08-28

摘要: 目的 探讨临床药师参与有氟康唑暴露史念珠菌血症患者治疗的对策及效果,为临床有效控制此类感染提供参考。 方法 在伏立康唑治疗该病患者效果不佳的情况下,临床药师建议采用米卡芬净抗念珠菌治疗。 结果 患者的念珠菌感染得到有效控制。 结论 米卡芬净能有效治疗近期(<30 d)有氟康唑暴露史的念珠菌血行感染。临床药师参与临床治疗实践,协助制订个体化治疗方案,有利于提高临床药物治疗水平。

English Abstract

秦又发, 张庆, 刘莉. 1例米卡芬净治疗有氟康唑暴露史念珠菌血症的病例分析及相关文献复习[J]. 药学实践与服务, 2016, 34(2): 181-183. doi: 10.3969/j.issn.1006-0111.2016.02.022
引用本文: 秦又发, 张庆, 刘莉. 1例米卡芬净治疗有氟康唑暴露史念珠菌血症的病例分析及相关文献复习[J]. 药学实践与服务, 2016, 34(2): 181-183. doi: 10.3969/j.issn.1006-0111.2016.02.022
shu
QIN Youfa, ZHANG Qing, LIU Li. Clinical analysis of 1 case of micafungin treatment: fluconazole-exposed candidemia and review of related literature[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(2): 181-183. doi: 10.3969/j.issn.1006-0111.2016.02.022
Citation: QIN Youfa, ZHANG Qing, LIU Li. Clinical analysis of 1 case of micafungin treatment: fluconazole-exposed candidemia and review of related literature[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(2): 181-183. doi: 10.3969/j.issn.1006-0111.2016.02.022
shu

    全文HTML

参考文献 (15)

目录

    /

    返回文章
    返回

    版权所有：《药学实践与服务》编辑委员会

    主管、主办: 中国人民解放军海军军医大学地址: 上海市杨浦区国和路325号邮政编码: 200433

    电话: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计